3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase EARLY_PHASE1
1
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Oncogenic osteomalacia
1
Nevus, Sebaceous of Jadassohn
1
Interventions
burosumab
1
Therapeutics
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Nevus, Sebaceous of Jadassohn
×
burosumab
×
Clear all
NCT04320316
2022-10-07
ENS
University of Alabama at Birmingham
Phase 4
Completed
1 enrolled
10 charts